• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Therapeutic polymer nanoreactor with site-specific activation of targeting Warburg metabolism for metastatic breast cancer treatment

Research Project

Project/Area Number 20K20209
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 90120:Biomaterials-related
Research InstitutionKyushu University (2022)
Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine (2020-2021)

Principal Investigator

LI JUNJIE  九州大学, 先導物質化学研究所, 准教授 (80869892)

Project Period (FY) 2020-04-01 – 2023-03-31
Project Status Completed (Fiscal Year 2022)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2022: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2021: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
KeywordsImmunotherapy / Nanoreactors / Pyroptosis / Self-assembly / Vesicles / Tumor metabolism / immunotherapy / nanoreactors / pyroptosis / self-assembly / vesicles / tumor metabolism / vesicle / nanoreactor / drug delivery
Outline of Research at the Start

The applicant will exploit the nanoreactor in the tumor-specific activation to simultaneously suppress breast tumor growth and metastasis. The glucose and lactate will be simultaneously consumed by oxidase-loaded nanoreactor with accompanying ROS production, which will aggravate metabolic stress.

Outline of Final Research Achievements

We developed a oxidase-loaded nanoreactor that could specifically render tumor cells immunogenic by pyroptosis, a highly pro-inflammatory programmed cell death. Of particular interest, the vesicular system based on PICsomes is highly modular, generic, and simple and could be adapted to customize various kinds of activatable nanoreactors based on triggerable cross-linking membrane networks. As a consequence, the nanoreactor with self-boosting catalytic glucose oxidation could protect oxidase to initiate pyroptosis in the long term. We confirmed that not only glucose oxidase-loaded but also lactate oxidase-loaded nanoreactors could induce pyroptosis. In combination with immunotherapy, the antitumor efficacy has been confirmed.

Academic Significance and Societal Importance of the Research Achievements

1. Scientific significance: a generic method has been developed to construct smart oxidase-loaded nanoreactor for specifically targeting tumor metabolism.
2. Social significance: Our nanoreactors can increase the potential of immunotherapy to bring more benefits to cancer patients.

Report

(4 results)
  • 2022 Annual Research Report   Final Research Report ( PDF )
  • 2021 Research-status Report
  • 2020 Research-status Report
  • Research Products

    (11 results)

All 2022 2021 2020

All Journal Article (7 results) (of which Int'l Joint Research: 6 results,  Peer Reviewed: 6 results) Presentation (2 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 1 results)

  • [Journal Article] Targeted nanomedicine in cisplatin-based cancer therapeutics2022

    • Author(s)
      Han Yu、Wen Panyue、Li Junjie、Kataoka Kazunori
    • Journal Title

      Journal of Controlled Release

      Volume: 345 Pages: 709-720

    • DOI

      10.1016/j.jconrel.2022.03.049

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Effective mRNA Protection by Poly(l-ornithine) Synergizes with Endosomal Escape Functionality of a Charge-Conversion Polymer toward Maximizing mRNA Introduction Efficiency2022

    • Author(s)
      A. Dirisala, S. Uchida, J. Li, J.F.R. Van Guyse, K. Hayashi, S.V.C. Vummaleti, S. Kaur, Y. Mochida, S. Fukushima, K. Kataoka
    • Journal Title

      Macromol. Rapid Commun.

      Volume: - Issue: 12 Pages: 2100754-2100754

    • DOI

      10.1002/marc.202100754

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Enzymatically Transformable Polymersome-Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer2021

    • Author(s)
      J. Li, Z. Ge, K. Toh, X. Liu, A. Dirisala, W. Ke, P. Wen, H. Zhou, Z. Wang, S. Xiao, J.F.R. Van Guyse, T.A. Tockary, J. Xie, D. Gonzalez-Carter, H. Kinoh, S. Uchida, Y. Anraku, K. Kataoka
    • Journal Title

      Adv. Mater.

      Volume: 33 Issue: 49 Pages: 2105254-2105254

    • DOI

      10.1002/adma.202105254

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Hypoxia-responsive block copolymer polyprodrugs for complementary photodynamic-chemotherapy2021

    • Author(s)
      Zhou Qinghao、Mohammed Fathelrahman、Wang Yuheng、Wang Jingbo、Lu Nannan、Li Junjie、Ge Zhishen
    • Journal Title

      Journal of Controlled Release

      Volume: 339 Pages: 130-142

    • DOI

      10.1016/j.jconrel.2021.09.023

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Tumor-dilated polymersome nanofactories for enhanced enzyme prodrug chemo-immunotherapy2021

    • Author(s)
      Japir Abd Al-Wali Mohammed M.、Ke Wendong、Li Junjie、Mukerabigwi Jean Felix、Ibrahim Alhadi、Wang Yuheng、Li Xiang、Zhou Qinghao、Mohammed Fathelrahman、Ge Zhishen
    • Journal Title

      Journal of Controlled Release

      Volume: 339 Pages: 418-429

    • DOI

      10.1016/j.jconrel.2021.10.015

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Self‐Boosting Catalytic Nanoreactor Integrated with Triggerable Crosslinking Membrane Networks for Initiation of Immunogenic Cell Death by Pyroptosis2020

    • Author(s)
      Junjie Li, Yasutaka Anraku, Kazunori Kataoka
    • Journal Title

      Angewandte Chemie International Edition

      Volume: - Issue: 32 Pages: 13526-13530

    • DOI

      10.1002/anie.202004180

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation2020

    • Author(s)
      Li Junjie、Kataoka Kazunori
    • Journal Title

      Journal of the American Chemical Society

      Volume: 143 Issue: 2 Pages: 538-559

    • DOI

      10.1021/jacs.0c09029

    • Related Report
      2020 Research-status Report
  • [Presentation] Glucose oxidase (GOD) as cancer therapeutics―GOD of Small Things2022

    • Author(s)
      Junjie Li
    • Organizer
      第29回次世代医工学研究会プログラム/The 29th Next Generation Medical Engineering Conference
    • Related Report
      2022 Annual Research Report
  • [Presentation] Strategies to advance functionality of polymeric nanomedicine2022

    • Author(s)
      Junjie Li
    • Organizer
      九州大学 先導物質化学研究所 特別講演会
    • Related Report
      2022 Annual Research Report
  • [Patent(Industrial Property Rights)] Non-fouling or super-stealth vesicle2022

    • Inventor(s)
      Junjie Li, Kazunori Kataoka
    • Industrial Property Rights Holder
      Junjie Li, Kazunori Kataoka
    • Industrial Property Rights Type
      特許
    • Filing Date
      2022
    • Related Report
      2022 Annual Research Report
  • [Patent(Industrial Property Rights)] Non-fouling or super-stealth vesicle2022

    • Inventor(s)
      Junjie Li, Kazunori Kataoka
    • Industrial Property Rights Holder
      Junjie Li, Kazunori Kataoka
    • Industrial Property Rights Type
      特許
    • Filing Date
      2022
    • Related Report
      2022 Annual Research Report
    • Overseas

URL: 

Published: 2020-04-28   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi